Sudoscan, a Noninvasive Tool for Detecting Diabetic Small Fiber Neuropathy and Autonomic Dysfunction

Overview

Journal Diabetes Technol Ther

Specialties Endocrinology
Pharmacology

Date 2013 Jul 30

PMID 23889506

Citations 124

Authors

Carolina M Casellini

Henri K Parson

Margaret S Richardson

Marie L Nevoret

Aaron I Vinik

Affiliations

Soon will be listed here.

Abstract

Objective: Sudomotor dysfunction may be an early detectable abnormality in diabetic small fiber neuropathy. The aim of this study was to evaluate the efficacy of Sudoscan™ (Impeto Medical, Paris, France) in detecting diabetic neuropathy (DN), in comparison with other standardized tests, in patients with diabetes mellitus (DM).

Subjects And Methods: Sudoscan measures electrochemical skin conductance (ESC) of hands and feet through reverse iontophoresis. We evaluated 83 DM patients with and without DN and 210 healthy controls (HCs). Neuropathy Impairment Score-Lower Legs (NIS-LL), quantitative autonomic function testing (QAFT), and quantitative sensory testing (QST) were performed. Symptomatic pain was recorded using a visual analog scale. Receiver-operator characteristic (ROC) curves were calculated to evaluate the efficacy of Sudoscan in detecting DN compared with traditional modalities.

Results: Diabetes patients with DN had significantly worse ESCs of feet and hands than DM patients without DN and HCs (respectively, 56.3±3 vs. 75.9±5.5 and 84.4±0.9 [P<0.0001] for feet and 51.9±2.4 vs. 67.5±4.3 and 73.1±0.8 [P<0.0001] for hands). Increasing NIS-LL scores were associated with decreasing ESC values. ESCs correlated significantly with clinical (NIS-LL), somatic (QST), and autonomic (QAFT) measures of neuropathy and with pain scores. ROC curve analysis showed significant results for both hands and feet ESC (area under the curve of 0.86 and 0.88, respectively; P<0.0001) with sensitivity of 78% and specificity of 92% for feet to detect DN.

Conclusions: Sudoscan is a promising, sensitive tool to detect neuropathy in patients with DM. This is a very simple, easy-to-perform test that can be done in the clinical setting in 3-5 min.

Citing Articles

Sensors and Devices Based on Electrochemical Skin Conductance and Bioimpedance Measurements for the Screening of Diabetic Foot Syndrome: Review and Meta-Analysis.

Verdini F, Mengarelli A, Chemello G, Salvatori B, Morettini M, Gobl C Biosensors (Basel). 2025; 15(2).

PMID: 39996975 PMC: 11852415. DOI: 10.3390/bios15020073.

Identification of small fiber neuropathy in neuronal intranuclear inclusion disease: A clinicopathological study.

Liu M, Liu R, Yuan Y, Liu X, Li L, Wang Y Alzheimers Dement. 2025; 21(2):e14596.

PMID: 39988644 PMC: 11847649. DOI: 10.1002/alz.14596.

Small fiber neuropathy in the post-COVID condition and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical significance and diagnostic challenges.

Azcue N, Teijeira-Portas S, Tijero-Merino B, Acera M, Fernandez-Valle T, Ayala U Eur J Neurol. 2025; 32(2):e70016.

PMID: 39888240 PMC: 11783232. DOI: 10.1111/ene.70016.

Sensory neuropathy in patients with Pompe disease: a case series in Iran.

Babaee M, Rahmati M, Dehdahsi S, Lochmuller H, Bahrami M, Zeinali V BMC Musculoskelet Disord. 2024; 25(1):1078.

PMID: 39731073 PMC: 11673344. DOI: 10.1186/s12891-024-08220-4.

Diagnostic Accuracy of Screening Tests for Diabetic Peripheral Neuropathy: An Umbrella Review.

Mogilevskaya M, Gaviria-Carrillo M, Feliciano-Alfonso J, Barragan A, Calderon-Ospina C, Nava-Mesa M J Diabetes Res. 2024; 2024():5902036.

PMID: 39664106 PMC: 11634407. DOI: 10.1155/jdr/5902036.

References

Witzke K, Vinik A, Grant L, Grant W, Parson H, Pittenger G . Loss of RAGE defense: a cause of Charcot neuroarthropathy?. Diabetes Care. 2011; 34(7):1617-21. PMC: 3120187. DOI: 10.2337/dc10-2315. View

Vinik A, Nevoret M, Casellini C, Parson H . Neurovascular function and sudorimetry in health and disease. Curr Diab Rep. 2013; 13(4):517-32. DOI: 10.1007/s11892-013-0392-x. View

McArthur J, Stocks E, Hauer P, Cornblath D, Griffin J . Epidermal nerve fiber density: normative reference range and diagnostic efficiency. Arch Neurol. 1998; 55(12):1513-20. DOI: 10.1001/archneur.55.12.1513. View

Hubert D, Brunswick P, Calvet J, Dusser D, Fajac I . Abnormal electrochemical skin conductance in cystic fibrosis. J Cyst Fibros. 2010; 10(1):15-20. DOI: 10.1016/j.jcf.2010.09.002. View

Vinik A, Ziegler D . Diabetic cardiovascular autonomic neuropathy. Circulation. 2007; 115(3):387-97. DOI: 10.1161/CIRCULATIONAHA.106.634949. View

Illigens B, Gibbons C . Sweat testing to evaluate autonomic function. Clin Auton Res. 2008; 19(2):79-87. PMC: 3046462. DOI: 10.1007/s10286-008-0506-8. View

Casellini C, Barlow P, Rice A, Casey M, Simmons K, Pittenger G . A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-beta inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy. Diabetes Care. 2007; 30(4):896-902. DOI: 10.2337/dc06-1699. View

Brunswick P, Mayaudon H, Albin V, Lair V, Ringuede A, Cassir M . Use of Ni electrodes chronoamperometry for improved diagnostics of diabetes and cardiac diseases. Annu Int Conf IEEE Eng Med Biol Soc. 2007; 2007:4544-7. DOI: 10.1109/IEMBS.2007.4353350. View

Tesfaye S, Boulton A, Dyck P, Freeman R, Horowitz M, Kempler P . Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010; 33(10):2285-93. PMC: 2945176. DOI: 10.2337/dc10-1303. View

10.

Alport A, W Sander H . Clinical approach to peripheral neuropathy: anatomic localization and diagnostic testing. Continuum (Minneap Minn). 2012; 18(1):13-38. DOI: 10.1212/01.CON.0000411546.13207.b1. View

11.

Fealey R, Low P, Thomas J . Thermoregulatory sweating abnormalities in diabetes mellitus. Mayo Clin Proc. 1989; 64(6):617-28. DOI: 10.1016/s0025-6196(12)65338-5. View

12.

Calvet J, Dupin J, Winiecki H, Schwarz P . Assessment of small fiber neuropathy through a quick, simple and non invasive method in a German diabetes outpatient clinic. Exp Clin Endocrinol Diabetes. 2012; 121(2):80-3. DOI: 10.1055/s-0032-1323777. View

13.

Dyck P, Overland C, Low P, Litchy W, Davies J, Dyck P . Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: Cl vs. NPhys trial. Muscle Nerve. 2010; 42(2):157-64. PMC: 2956592. DOI: 10.1002/mus.21661. View

14.

Moak J, Goldstein D, Eldadah B, Saleem A, Holmes C, Pechnik S . Supine low-frequency power of heart rate variability reflects baroreflex function, not cardiac sympathetic innervation. Cleve Clin J Med. 2009; 76 Suppl 2:S51-9. DOI: 10.3949/ccjm.76.s2.11. View

15.

Yajnik C, Kantikar V, Pande A, Deslypere J . Quick and simple evaluation of sudomotor function for screening of diabetic neuropathy. ISRN Endocrinol. 2012; 2012:103714. PMC: 3399356. DOI: 10.5402/2012/103714. View

16.

Dyck P . Detection, characterization, and staging of polyneuropathy: assessed in diabetics. Muscle Nerve. 1988; 11(1):21-32. DOI: 10.1002/mus.880110106. View

17.

Gin H, Baudoin R, Raffaitin C, Rigalleau V, Gonzalez C . Non-invasive and quantitative assessment of sudomotor function for peripheral diabetic neuropathy evaluation. Diabetes Metab. 2011; 37(6):527-32. DOI: 10.1016/j.diabet.2011.05.003. View

18.

Vinik A, Erbas T, Park T, Pierce K, Stansberry K . Methods for evaluation of peripheral neurovascular dysfunction. Diabetes Technol Ther. 2001; 3(1):29-50. DOI: 10.1089/152091501750220000. View

19.

La Rovere M, Pinna G, Maestri R, Sleight P . Clinical value of baroreflex sensitivity. Neth Heart J. 2012; 21(2):61-3. PMC: 3547421. DOI: 10.1007/s12471-012-0349-8. View

20.

Mayaudon H, Miloche P, Bauduceau B . A new simple method for assessing sudomotor function: relevance in type 2 diabetes. Diabetes Metab. 2010; 36(6 Pt 1):450-4. DOI: 10.1016/j.diabet.2010.05.004. View